Colombia's healthcare crisis claimed another life as Jeisson Pinzón, a 20-year-old leukemia patient from Tunja, died after waiting four months for medication his doctors deemed essential, despite winning a constitutional court order demanding his treatment.
The case, reported by Minuto60, exposes systemic failures in Colombia's EPS health insurance system, where legal victories mean little when private insurers simply ignore court orders.
Pinzón was diagnosed with acute lymphoblastic leukemia in February 2025. By October, his doctors prescribed Blinatumomab, a medication required to prepare him for a bone marrow transplant that could save his life. Nueva EPS, his health insurer, never delivered it.
His family pursued every available legal remedy. They filed a tutela—Colombia's constitutional protection mechanism for fundamental rights—and won. When Nueva EPS ignored the favorable ruling, they filed a desacato contempt action to enforce the court order. Neither worked. Pinzón died March 14, his disease progressing beyond treatment while bureaucrats delayed.
<h2>A Treatable Disease Left Untreated</h2>
A foundation president familiar with the case stated the disease "could be treated," but medication delays "blocked the possibility of controlling relapse" and prevented access to transplant treatment. Pinzón's death was preventable—a casualty not of medical science but of administrative indifference.
The tragedy extends beyond one young man. According to patient advocacy groups, Nueva EPS alone faces approximately 120,000 unresolved tutelas—court orders demanding care that the insurer has not provided. At least 15 other hematologic cancer patients currently face delays similar to those that killed Pinzón.
The case has been included in a complaint before the Inter-American Commission on Human Rights, joining dozens of other healthcare rights violations that have prompted international scrutiny of Colombia's health system.

